My understanding is that for CWH, EBOS/Symbion supplies ethicals, and DHL supplies FMCG, this includes majority OTC products if CWH does not buy/distribute direct via their own DCs. DHL has been trying to play the Sigma/Symbion/API roles previously, thru their distribution of Pfizer and Astrazeneca products. As their operation is funded globally, it could be loss-leading in an attempt to grab market share here in AU, but it will not be an easy task, sacrificing service for competitive margin.
Ann: Market Update, page-8
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SIG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.005(0.38%) |
Mkt cap ! $2.129B | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.34 | $1.29 | $22.96M | 17.55M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 198520 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 638785 | 14 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| SIG (ASX) Chart |